Metabolomic biomarkers of pancreatic cancer: a meta-analysis study

Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and diagnosis of this disease. Several research groups have reported on metabolomics based clinical investigations to identify biomarkers of PC, however there is a lack of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Khyati Y., Wu, Hung-Jen, Menon, Smrithi S., Fallah, Yassi, Zhong, Xiaogang, Rizk, Nasser, Unger, Keith, Mapstone, Mark, Fiandaca, Massimo S., Federoff, Howard J., Cheema, Amrita K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620306/
https://www.ncbi.nlm.nih.gov/pubmed/28978166
http://dx.doi.org/10.18632/oncotarget.20324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620306/
https://www.ncbi.nlm.nih.gov/pubmed/28978166
http://dx.doi.org/10.18632/oncotarget.20324

Ejemplares similares